Further research is needed to determine whether RTX changes intracellular signalling of MAPK and ERK1/2 phosphorylation which is reported to be delayed in CFS/ME patients [53]. This evidence concerns the gene MAPK3 and myalgic encephalomeyelitis/chronic fatigue syndrome.